{"protocolSection":{"identificationModule":{"nctId":"NCT05557409","orgStudyIdInfo":{"id":"AXS-05-AD-304"},"organization":{"fullName":"Axsome Therapeutics, Inc.","class":"INDUSTRY"},"briefTitle":"A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation","officialTitle":"ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease Agitation","acronym":"ADVANCE-2"},"statusModule":{"statusVerifiedDate":"2026-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-09-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-11-21","type":"ACTUAL"},"completionDateStruct":{"date":"2024-12-21","type":"ACTUAL"},"studyFirstSubmitDate":"2022-09-23","studyFirstSubmitQcDate":"2022-09-23","studyFirstPostDateStruct":{"date":"2022-09-28","type":"ACTUAL"},"resultsFirstSubmitDate":"2026-05-29","resultsFirstSubmitQcDate":"2026-07-22","resultsFirstPostDateStruct":{"date":"2026-08-13","type":"ACTUAL"},"dispFirstSubmitDate":"2025-11-20","dispFirstPostDateStruct":{"date":"2026-08-13","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-07-22","lastUpdatePostDateStruct":{"date":"2026-08-13","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Axsome Therapeutics, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This trial was a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.","detailedDescription":"Eligible subjects were randomized in a 1:1 ratio for up to 5 weeks to be treated with AXS-05 or placebo."},"conditionsModule":{"conditions":["Agitation in Patients With Dementia of the Alzheimer's Type","Alzheimer Disease","Agitation"],"keywords":["AD agitation","AXS-05","NMDA receptor antagonist","dextromethorphan","bupropion","Axsome","ADVANCE-2"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR"]}},"enrollmentInfo":{"count":408,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"AXS-05","type":"EXPERIMENTAL","description":"Up to 5 weeks","interventionNames":["Drug: AXS-05"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Up to 5 weeks","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"AXS-05","description":"AXS-05 tablets, taken twice daily","armGroupLabels":["AXS-05"]},{"type":"DRUG","name":"Placebo","description":"Placebo tablets, taken twice daily","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Cohen-Mansfield Agitation Inventory (CMAI)","description":"The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item caregiver-rated questionnaire that assesses the frequency of agitation-related and disruptive behaviors in subjects with dementia. The scale contains 29 behaviors or items organized into four subscales: physically aggressive, physically non-aggressive, verbally aggressive, and verbally non-aggressive. The CMAI is administered by interviewing the caregiver and asking him or her to rate the frequency with which the subject manifests each behavior using a seven-point scale: 1=never (better outcome), 7=several times an hour (worse outcome). The CMAI total score is the sum of the scores for all of the items in the CMAI. CMAI total scores range from a minimum of 29 (better outcome) to a maximum of 203 (worse outcome).","timeFrame":"Up to 5 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of probable Alzheimer's disease (AD) based on the 2011 National Institute on Aging-Alzheimer Association (NIA-AA) criteria.\n* Diagnosis of clinically significant agitation resulting from probable AD according to the International Psychogeriatric Association (IPA) provisional definition of agitation.\n\nExclusion Criteria:\n\n* Patient has dementia predominantly of non-Alzheimer's type.\n* Unable to comply with study procedures.\n* Medically inappropriate for study participation in the opinion of the investigator.","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","maximumAge":"90 Years","stdAges":["OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Clinical Research Site","city":"Peoria","state":"Arizona","zip":"85381","country":"United States","geoPoint":{"lat":33.5806,"lon":-112.23738}},{"facility":"Clinical Research Site","city":"Tempe","state":"Arizona","zip":"85282","country":"United States","geoPoint":{"lat":33.41477,"lon":-111.90931}},{"facility":"Clinical Research Site","city":"Tucson","state":"Arizona","zip":"85710","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Clinical Research Site","city":"Canoga Park","state":"California","zip":"91303","country":"United States","geoPoint":{"lat":34.20112,"lon":-118.59814}},{"facility":"Clinical Research Site","city":"Long Beach","state":"California","zip":"90807","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"Clinical Research Site","city":"Los Alamitos","state":"California","zip":"90720","country":"United States","geoPoint":{"lat":33.80307,"lon":-118.07256}},{"facility":"Clinical Research Site","city":"Walnut Creek","state":"California","zip":"94596","country":"United States","geoPoint":{"lat":37.90631,"lon":-122.06496}},{"facility":"Clinical Research Site","city":"West Covina","state":"California","zip":"91790","country":"United States","geoPoint":{"lat":34.06862,"lon":-117.93895}},{"facility":"Clinical Research Site","city":"Bonita Springs","state":"Florida","zip":"34134","country":"United States","geoPoint":{"lat":26.33981,"lon":-81.7787}},{"facility":"Clinical Research Site","city":"Brandon","state":"Florida","zip":"33511","country":"United States","geoPoint":{"lat":27.9378,"lon":-82.28592}},{"facility":"Clinical Research Site","city":"Green Acres","state":"Florida","zip":"33467","country":"United States","geoPoint":{"lat":27.727,"lon":-82.4307}},{"facility":"Clinical Research Site","city":"Hialeah","state":"Florida","zip":"33012","country":"United States","geoPoint":{"lat":25.8576,"lon":-80.27811}},{"facility":"Clinical Research Site","city":"Hollywood","state":"Florida","zip":"33024","country":"United States","geoPoint":{"lat":26.0112,"lon":-80.14949}},{"facility":"Clinical Research Site","city":"Kissimmee","state":"Florida","zip":"34741","country":"United States","geoPoint":{"lat":28.30468,"lon":-81.41667}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33126","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33135","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33145","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33155","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33165","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33173","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami","state":"Florida","zip":"33175","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Clinical Research Site","city":"Miami Gardens","state":"Florida","zip":"33014","country":"United States","geoPoint":{"lat":25.94204,"lon":-80.2456}},{"facility":"Clinical Research Site","city":"Miami Lakes","state":"Florida","zip":"33014","country":"United States","geoPoint":{"lat":25.90871,"lon":-80.30866}},{"facility":"Clinical Research Site","city":"Orlando","state":"Florida","zip":"32807","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Clinical Research Site","city":"Pembroke Pines","state":"Florida","zip":"33025","country":"United States","geoPoint":{"lat":26.00315,"lon":-80.22394}},{"facility":"Clinical Research Site","city":"Tampa","state":"Florida","zip":"33614","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Clinical Research Site","city":"Tampa","state":"Florida","zip":"33634","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Clinical Research Site","city":"Augusta","state":"Georgia","zip":"30912","country":"United States","geoPoint":{"lat":33.47097,"lon":-81.97484}},{"facility":"Clinical Research Site","city":"College Park","state":"Georgia","zip":"30349","country":"United States","geoPoint":{"lat":33.65344,"lon":-84.44937}},{"facility":"Clinical Research Site","city":"Columbus","state":"Georgia","zip":"31909","country":"United States","geoPoint":{"lat":32.46098,"lon":-84.98771}},{"facility":"Clinical Research Site","city":"Wichita","state":"Kansas","zip":"67214","country":"United States","geoPoint":{"lat":37.69224,"lon":-97.33754}},{"facility":"Clinical Research Site","city":"Marrero","state":"Louisiana","zip":"70072","country":"United States","geoPoint":{"lat":29.89937,"lon":-90.10035}},{"facility":"Clinical Research Site","city":"Braintree","state":"Massachusetts","zip":"02184","country":"United States","geoPoint":{"lat":42.20384,"lon":-71.00215}},{"facility":"Clinical Research Site","city":"Flint","state":"Michigan","zip":"48532","country":"United States","geoPoint":{"lat":43.01253,"lon":-83.68746}},{"facility":"Clinical Research Site","city":"Rochester Hills","state":"Michigan","zip":"48307","country":"United States","geoPoint":{"lat":42.65837,"lon":-83.14993}},{"facility":"Clinical Research Site","city":"Troy","state":"Michigan","zip":"48085","country":"United States","geoPoint":{"lat":42.60559,"lon":-83.14993}},{"facility":"Clinical Research Site","city":"Chesterfield","state":"Missouri","zip":"63005","country":"United States","geoPoint":{"lat":38.66311,"lon":-90.57707}},{"facility":"Clinical Research Site","city":"Berlin","state":"New Jersey","zip":"08009","country":"United States","geoPoint":{"lat":39.79123,"lon":-74.92905}},{"facility":"Clinical Research Site","city":"Toms River","state":"New Jersey","zip":"08755","country":"United States","geoPoint":{"lat":39.95373,"lon":-74.19792}},{"facility":"Clinical Research Site","city":"Brooklyn","state":"New York","zip":"11229","country":"United States","geoPoint":{"lat":40.6501,"lon":-73.94958}},{"facility":"Clinical Research Site","city":"New Windsor","state":"New York","zip":"12553","country":"United States","geoPoint":{"lat":41.47676,"lon":-74.02375}},{"facility":"Clinical Research Site","city":"Staten Island","state":"New York","zip":"10314","country":"United States","geoPoint":{"lat":40.56233,"lon":-74.13986}},{"facility":"Clinical Research Site","city":"Woodmere","state":"New York","zip":"11598","country":"United States","geoPoint":{"lat":40.63205,"lon":-73.71263}},{"facility":"Clinical Research Site","city":"Charlotte","state":"North Carolina","zip":"28211","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"Clinical Research Site","city":"Hickory","state":"North Carolina","zip":"28601","country":"United States","geoPoint":{"lat":35.73319,"lon":-81.3412}},{"facility":"Clinical Research Site","city":"Middleburg Heights","state":"Ohio","zip":"44130","country":"United States","geoPoint":{"lat":41.36144,"lon":-81.81291}},{"facility":"Clinical Research Site","city":"Austin","state":"Texas","zip":"78737","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Clinical Research Site","city":"Cypress","state":"Texas","zip":"77429","country":"United States","geoPoint":{"lat":29.96911,"lon":-95.69717}},{"facility":"Clinical Research Site","city":"Mesquite","state":"Texas","zip":"75149","country":"United States","geoPoint":{"lat":32.7668,"lon":-96.59916}},{"facility":"Clinical Research Site","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Clinical Research Site","city":"Sugarland","state":"Texas","zip":"77478","country":"United States"},{"facility":"Clinical Research Site","city":"Rutland","state":"Vermont","zip":"05701","country":"United States","geoPoint":{"lat":43.61062,"lon":-72.97261}},{"facility":"Clinical Research Site","city":"Arlington","state":"Virginia","zip":"22205","country":"United States","geoPoint":{"lat":38.88101,"lon":-77.10428}},{"facility":"Clinical Research Site","city":"Bayamón","state":"Puerto Rico","zip":"00961","country":"Puerto Rico","geoPoint":{"lat":18.39856,"lon":-66.15572}},{"facility":"Clinical Research Site","city":"San Juan","state":"Puerto Rico","zip":"00918","country":"Puerto Rico","geoPoint":{"lat":18.46633,"lon":-66.10572}}]},"referencesModule":{"seeAlsoLinks":[{"label":"Axsome Therapeutics Website","url":"http://axsome.com/"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"AXS-05","description":"Up to 5 weeks\n\nAXS-05: AXS-05 tablets, taken twice daily"},{"id":"FG001","title":"Placebo","description":"Up to 5 weeks\n\nPlacebo: Placebo tablets, taken twice daily"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"204"},{"groupId":"FG001","numSubjects":"204"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"194"},{"groupId":"FG001","numSubjects":"194"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"10"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"AXS-05","description":"Up to 5 weeks\n\nAXS-05: AXS-05 tablets, taken twice daily"},{"id":"BG001","title":"Placebo","description":"Up to 5 weeks\n\nPlacebo: Placebo tablets, taken twice daily"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"204"},{"groupId":"BG001","value":"204"},{"groupId":"BG002","value":"408"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"73.6","spread":"5.34"},{"groupId":"BG001","value":"75.0","spread":"5.74"},{"groupId":"BG002","value":"74.3","spread":"5.58"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"130"},{"groupId":"BG001","value":"112"},{"groupId":"BG002","value":"242"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"92"},{"groupId":"BG002","value":"166"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"Black or African American","categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"41"}]}]},{"title":"Asian","categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}]}]},{"title":"White","categories":[{"measurements":[{"groupId":"BG000","value":"184"},{"groupId":"BG001","value":"178"},{"groupId":"BG002","value":"362"}]}]},{"title":"Other","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Cohen-Mansfield Agitation Inventory (CMAI)","description":"The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item caregiver-rated questionnaire that assesses the frequency of agitation-related and disruptive behaviors in subjects with dementia. The scale contains 29 behaviors or items organized into four subscales: physically aggressive, physically non-aggressive, verbally aggressive, and verbally non-aggressive. The CMAI is administered by interviewing the caregiver and asking him or her to rate the frequency with which the subject manifests each behavior using a seven-point scale: 1=never (better outcome), 7=several times an hour (worse outcome). The CMAI total score is the sum of the scores for all of the items in the CMAI. CMAI total scores range from a minimum of 29 (better outcome) to a maximum of 203 (worse outcome).","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"score on a scale","timeFrame":"Up to 5 weeks","groups":[{"id":"OG000","title":"AXS-05","description":"Up to 5 weeks\n\nAXS-05: AXS-05 tablets, taken twice daily"},{"id":"OG001","title":"Placebo","description":"Up to 5 weeks\n\nPlacebo: Placebo tablets, taken twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"204"},{"groupId":"OG001","value":"204"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.85","spread":"0.917"},{"groupId":"OG001","value":"-12.77","spread":"0.921"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.407","statisticalMethod":"Mixed Models Analysis"}]}]},"adverseEventsModule":{"frequencyThreshold":"3","timeFrame":"Treatment emergent adverse events (TEAEs) were collected after administration of study drug through 7 days after the last dose (up to 5 weeks).","eventGroups":[{"id":"EG000","title":"AXS-05","description":"Up to 5 weeks\n\nAXS-05: AXS-05 tablets, taken twice daily","deathsNumAffected":0,"deathsNumAtRisk":204,"seriousNumAffected":2,"seriousNumAtRisk":204,"otherNumAffected":27,"otherNumAtRisk":204},{"id":"EG001","title":"Placebo","description":"Up to 5 weeks\n\nPlacebo: Placebo tablets, taken twice daily","deathsNumAffected":0,"deathsNumAtRisk":204,"seriousNumAffected":0,"seriousNumAtRisk":204,"otherNumAffected":15,"otherNumAtRisk":204}],"seriousEvents":[{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204}]}],"otherEvents":[{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":12,"numAtRisk":204},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":204}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":204},{"groupId":"EG001","numEvents":8,"numAffected":7,"numAtRisk":204}]},{"term":"Somnolence","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Dictionary","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":204},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":204}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":true},"pointOfContact":{"title":"Study Director","organization":"Axsome Therapeutics","email":"cstreicher@axsome.com","phone":"212-332-5061"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2022-06-02","uploadDate":"2026-05-29T15:09","filename":"Prot_SAP_000.pdf","size":539771}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-10-13","submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2026-06-25","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D000544","term":"Alzheimer Disease"},{"id":"D011595","term":"Psychomotor Agitation"}],"ancestors":[{"id":"D003704","term":"Dementia"},{"id":"D001927","term":"Brain Diseases"},{"id":"D002493","term":"Central Nervous System Diseases"},{"id":"D009422","term":"Nervous System Diseases"},{"id":"D024801","term":"Tauopathies"},{"id":"D019636","term":"Neurodegenerative Diseases"},{"id":"D019965","term":"Neurocognitive Disorders"},{"id":"D001523","term":"Mental Disorders"},{"id":"D020820","term":"Dyskinesias"},{"id":"D009461","term":"Neurologic Manifestations"},{"id":"D011596","term":"Psychomotor Disorders"},{"id":"D019954","term":"Neurobehavioral Manifestations"},{"id":"D012816","term":"Signs and Symptoms"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"},{"id":"D000096762","term":"Aberrant Motor Behavior in Dementia"},{"id":"D001526","term":"Behavioral Symptoms"},{"id":"D001519","term":"Behavior"}]}},"hasResults":true}